For prostate cancer patients, risk-specific therapies now more the norm
Friday, July 24, 2015 - 09:20
in Health & Medicine
After decades of overtreatment for low-risk prostate cancer and inadequate management of its more aggressive forms, patients are now more likely to receive medical care matched to level of risk, according to a study.